May 12, 2024, 14:36
Erman Akkus: Low-Grade Glioma Management summarized by ASCO Educational Book
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Low-Grade Glioma Management
ASCO Educational Book
- IDH1/2 and BRAF are frequently altered, should be tested in all patients
- IDH inhibitor therapy may be considered in patients who have not received radiation or chemotherapy
- BRAF inhibitor therapy is an appropriate first line for patients with BRAF V600E-altered low-grade glioma.”
Read further.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 16, 2025, 17:18
Jan 16, 2025, 16:45
Jan 16, 2025, 16:28
Jan 16, 2025, 16:10
Jan 16, 2025, 16:03
Jan 16, 2025, 15:57
Jan 16, 2025, 15:50
Jan 16, 2025, 15:46